Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Gastrointestinal Disorders”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Early research (Phase 1)Study completedNCT00004806
What this trial is testing

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Alabama at Birmingham 9
Early research (Phase 1)Study completedNCT00004471
What this trial is testing

Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer

Who this might be right for
Cystic Fibrosis
University of Alabama at Birmingham 9
Not applicableEnrolling By InvitationNCT07417267
What this trial is testing

Clean Air for Rare MUcociliary Clearance dIsorders

Who this might be right for
Primary Ciliary Dyskinesia (PCD)Cystic Fibrosis (CF)
University of Cyprus 62
Not applicableStudy completedNCT05917236
What this trial is testing

Biliary Atresia With Rare Associations, a Case Report

Who this might be right for
BA - Biliary Atresia
Sarah Magdy Abdelmohsen 1
Not applicableStudy completedNCT01880983
What this trial is testing

Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))

Who this might be right for
Erythropoietic Protoporphyria (EPP)
University of Alabama at Birmingham 150
Not applicableStudy completedNCT05793385
What this trial is testing

The Uncommon Complications of Meckel's Diverticulum

Who this might be right for
To Report the Rare Occurrence of Meckel's Diverticulum
Haramaya Unversity 4
Post-approval studies (Phase 4)Study completedNCT00004338
What this trial is testing

Study of Zinc for Wilson Disease

Who this might be right for
Wilson Disease
National Center for Research Resources (NCRR) 300
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Not applicableStudy completedNCT00005103
What this trial is testing

Study of the Pathogenesis of Porphyria Cutanea Tarda

Who this might be right for
Porphyria Cutanea Tarda
National Center for Research Resources (NCRR) 120
Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Not applicableLooking for participantsNCT07128966
What this trial is testing

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Who this might be right for
HealthyLupusCeliac+3 more
Joined Bio 100,000
Large-scale testing (Phase 3)Looking for participantsNCT07440290
What this trial is testing

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+17 more
Cancer Research UK 30
Not applicableStudy completedNCT00004414
What this trial is testing

Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis

Who this might be right for
Cholestasis
University of Michigan 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Not applicableEnded earlyNCT00014768
What this trial is testing

Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Center for Research Resources (NCRR) 36
Early research (Phase 1)Study completedNCT00004842
What this trial is testing

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Who this might be right for
Cholangitis, SclerosingLiver Cirrhosis, Biliary
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 22
Large-scale testing (Phase 3)Looking for participantsNCT05770102
What this trial is testing

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Who this might be right for
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Testing effectiveness (Phase 2)Study completedNCT00004787
What this trial is testing

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Who this might be right for
Shwachman SyndromeFanconi's AnemiaDyskeratosis Congenita+1 more
National Center for Research Resources (NCRR) 20
Next Page